Narcolepsy in children: An overlooked diagnosis;Narkolepsi hos børn - En overset diagnose

Ugeskrift for Laeger

Volumn 167, Issue 22, 2005, Pages 2390-2393

  Møller, Lene Ruge ^a   Østergaard, John R ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; HLA DQB1 ANTIGEN; HLA DR2 ANTIGEN; IMIPRAMINE; METHYLPHENIDATE; MODAFINIL; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VENLAFAXINE;

CATAPLEXY; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; DENMARK; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; DRUG EFFICACY; EARLY DIAGNOSIS; HUMAN; HYPNAGOGIC HALLUCINATION; INTELLECTUAL IMPAIRMENT; NARCOLEPSY; PATHOPHYSIOLOGY; PSYCHOSOCIAL DISORDER; REVIEW; SOMNOLENCE; SYMPTOM;

AGE OF ONSET; CHILD; HUMANS; NARCOLEPSY;

EID: 20644460376     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Stores G. Recognition and management of narcolepsy. Arch Dis Child 1998; 81:519-24.
2. Guilleminault C. Narcolepsy in prepubertal children. Ann Neurol 1998;43: 135-42.
3. Merrill S, Wise MD. Childhood narcolepsy. Neurology 1998;50(suppl 1): S37-S42.
4. Guilleminault C, Pelayo R. Nacolepsy in children. Paediatr Drugs 2000; 2-9.
5. McKenna L, McNicholas F. Childhood onset narcolepsy. Eur Child Adolesc Psychiatry 2003;12:43-7.
6. Dahl RE, Holttum J, Trudnick L. A clinical picture of child and adolescent narcolepsy. J Am Acad Child Adolesc Psychiatry 1994;33:834-41.
7. Heler MS. Narkolepsy in children-a diagnostic and therapeutic challenge. Tidsskr Nor Laegeforen 1998;118:2961-3.
8. Challamel MJ, Mazzola ME, Nevsimalova S et al. Narcolepsy in children. Sleep 1994;17:517-20.
9. Pearl PL. Childhood sleep disorders: diagnostic and therapeutic approaches. Curr Neurol Neurosci Rep 2002;2:150-7.
10. Overeem S, Mignot E, van Dijk J et al. Narcolepsy: clinical features, new pathophysioiogic insights, and future perspectives. J Clinical Neurophysiol 2001;18:78-105.
11. Scammell, TE. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 2003;53:154-66.
12. Ohayon MM, Priest RG. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology 2002;58:1826-33.
13. Silber MH, Krahn LE, Olson EJ et al. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep 2002;25:197-202.
14. Sharp SJ, D'Cruz OF. Narcolepsy in a 12-month-old-boy. J Child Neurol 2001;16:145-6.
15. Bell IR. Diet histories in narcolepsy. I: Guilleminault C, Dement WC, Passouant P, eds. Narcolepsy. New York; Spectrum, 1976: 221-8
16. Lammers GJ, Piji H, Iestra J et al. Spontaneous food choice in narcolepsy. Sleep 1996;19:5-6.
17. Schuld A, Hebebrand J, Geller F et al. Increased body-mass index in patients with narcolepsy. Lancet 2000b;355:1274-5.
18. Middelkoop HA, Lammers GJ, van Hilten BJ et al. Circadian distribution of motor activity and immobility in narcolepsy: assessment with continuous motor activity monitoring. Psychophysiology 1995;32:286-91.
19. Nishino S, Okura M, Mignot E. Narcolepsy:genetic predisposition and neuropharmacological mechanisms. Sleep Med Rev 2000;4(1):57-99.
20. Ebrahim IO, Sharief MK, de Lacy S et al. Hypocretin (oresin) deficiency in narcolepsy and primary hypersomnia. J Neurol Neurosurg Psychiatry 2003; 74:127-30.
21. Mignot E, Lammers GJ. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-62.
22. Taylor MM, Samson WK. The other side of the orexins: endocrine and metabolic actions. Am J Physiol Endocrinol Metab 20003;284:E13-17.
23. Kotagal S, Goulding PM. The laboratory assessment of daytime sleepiness in childhood. J Clin Neurophysiol 1996;13:208-18.
24. Tsukamoto H, Ishikawa T. Undetectable levels of CSF hypocretin-1 in two prepubertal boys with narcolepsy. Neuropediatrics 2002;33:51-2.
25. Dalgaard S, Thomsen PH. Evidensbaseret behandling af ADHD/DAMP- børn og unge med centralstimulerende medicin. Ugeskr Læger 2001;163:1116-21.
26. Mitler MM, Harsh J, Hirshkowitz M et al. Long-term efficacy and safety of modafinil (Provigil) for the treatment of excessive daytime sleepiness associated with narcolepsy. Sleep Med 2000;1:231-43.
27. Fry JM. Treatment modalities for narcolepsy. Neurology 1998;50(suppl 1): S43-8.
28. Thirumalai SS, Shubin RA. The use of citalopram in resistant cataplexy. Sleep Med 2000;1:313-6.